Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform
Year of publication: |
2022
|
---|---|
Authors: | Brekke, Kurt Richard ; Canta, Chiara ; Straume, Odd Rune |
Publisher: |
[S.l.] : SSRN |
Subject: | Generika | Generic drugs | Preisdifferenzierung | Price discrimination | Preiswettbewerb | Price competition | Norwegen | Norway | Wirkungsanalyse | Impact assessment | Arzneimittel | Pharmaceuticals |
Extent: | 1 Online-Ressource (47 p) |
---|---|
Series: | CESifo Working Paper ; No. 9853 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments 2022 erstellt |
Other identifiers: | 10.2139/ssrn.4169387 [DOI] |
Classification: | I11 - Analysis of Health Care Markets ; I18 - Government Policy; Regulation; Public Health ; L13 - Oligopoly and Other Imperfect Markets ; L65 - Chemicals; Rubber; Drugs; Biotechnology |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Brekke, Kurt R., (2022)
-
Brekke, Kurt Richard, (2015)
-
Brekke, Kurt R., (2010)
- More ...
-
Reference pricing with endogenous generic entry
Brekke, Kurt R., (2015)
-
Brekke, Kurt R., (2015)
-
Hospital Competition in the National Health Service : Evidence from a Patient Choice Reform
Brekke, Kurt Richard, (2018)
- More ...